Hepatitis vaccination among drug users

Gianluca Quaglio, Fabio Lugoboni, Paolo Mezzelani, Don Des Jarlais, Alessandro Lechi

Research output: Contribution to journalReview article

Abstract

Hepatitis virus infections are traditionally a major health problem among drug users (DUs). Several factors may favor the rapid spread of hepatitis infection in this category of patients. HBV and HCV are easily transmitted through exposure to infected blood and body fluids. DUs often prepare and use drug solutions together. Many in the DU community are infected and this provides multiple opportunities for transmission to others. Many of these patients with chronic hepatitis virus infection are not aware of their infections and this facilitates the spread of the diseases. Viral hepatitis is not inevitable for DUs. Although multiple factors have prevented the development of vaccines for hepatitis C, both hepatitis A and hepatitis B can be prevented by immunization. The purpose of this overview is to summarize and discuss the hepatitis vaccination in this population.

Original languageEnglish (US)
Pages (from-to)2702-2709
Number of pages8
JournalVaccine
Volume24
Issue number15
DOIs
StatePublished - Apr 5 2006

Fingerprint

hepatitis
Drug Users
Hepatitis
Vaccination
vaccination
drugs
Hepatitis Viruses
Virus Diseases
infection
Hepatitis A
viral hepatitis
Body Fluids
hepatitis C
chronic hepatitis
Chronic Hepatitis
Hepatitis C
hepatitis A
Infection
Hepatitis B
viruses

Keywords

  • Drug users
  • HAV
  • HBV
  • HCV
  • Hepatitis vaccination

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Quaglio, G., Lugoboni, F., Mezzelani, P., Des Jarlais, D., & Lechi, A. (2006). Hepatitis vaccination among drug users. Vaccine, 24(15), 2702-2709. https://doi.org/10.1016/j.vaccine.2005.12.045

Hepatitis vaccination among drug users. / Quaglio, Gianluca; Lugoboni, Fabio; Mezzelani, Paolo; Des Jarlais, Don; Lechi, Alessandro.

In: Vaccine, Vol. 24, No. 15, 05.04.2006, p. 2702-2709.

Research output: Contribution to journalReview article

Quaglio, G, Lugoboni, F, Mezzelani, P, Des Jarlais, D & Lechi, A 2006, 'Hepatitis vaccination among drug users', Vaccine, vol. 24, no. 15, pp. 2702-2709. https://doi.org/10.1016/j.vaccine.2005.12.045
Quaglio G, Lugoboni F, Mezzelani P, Des Jarlais D, Lechi A. Hepatitis vaccination among drug users. Vaccine. 2006 Apr 5;24(15):2702-2709. https://doi.org/10.1016/j.vaccine.2005.12.045
Quaglio, Gianluca ; Lugoboni, Fabio ; Mezzelani, Paolo ; Des Jarlais, Don ; Lechi, Alessandro. / Hepatitis vaccination among drug users. In: Vaccine. 2006 ; Vol. 24, No. 15. pp. 2702-2709.
@article{5bf5e449126e44fc9bd62aa208dc8d28,
title = "Hepatitis vaccination among drug users",
abstract = "Hepatitis virus infections are traditionally a major health problem among drug users (DUs). Several factors may favor the rapid spread of hepatitis infection in this category of patients. HBV and HCV are easily transmitted through exposure to infected blood and body fluids. DUs often prepare and use drug solutions together. Many in the DU community are infected and this provides multiple opportunities for transmission to others. Many of these patients with chronic hepatitis virus infection are not aware of their infections and this facilitates the spread of the diseases. Viral hepatitis is not inevitable for DUs. Although multiple factors have prevented the development of vaccines for hepatitis C, both hepatitis A and hepatitis B can be prevented by immunization. The purpose of this overview is to summarize and discuss the hepatitis vaccination in this population.",
keywords = "Drug users, HAV, HBV, HCV, Hepatitis vaccination",
author = "Gianluca Quaglio and Fabio Lugoboni and Paolo Mezzelani and {Des Jarlais}, Don and Alessandro Lechi",
year = "2006",
month = "4",
day = "5",
doi = "10.1016/j.vaccine.2005.12.045",
language = "English (US)",
volume = "24",
pages = "2702--2709",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "15",

}

TY - JOUR

T1 - Hepatitis vaccination among drug users

AU - Quaglio, Gianluca

AU - Lugoboni, Fabio

AU - Mezzelani, Paolo

AU - Des Jarlais, Don

AU - Lechi, Alessandro

PY - 2006/4/5

Y1 - 2006/4/5

N2 - Hepatitis virus infections are traditionally a major health problem among drug users (DUs). Several factors may favor the rapid spread of hepatitis infection in this category of patients. HBV and HCV are easily transmitted through exposure to infected blood and body fluids. DUs often prepare and use drug solutions together. Many in the DU community are infected and this provides multiple opportunities for transmission to others. Many of these patients with chronic hepatitis virus infection are not aware of their infections and this facilitates the spread of the diseases. Viral hepatitis is not inevitable for DUs. Although multiple factors have prevented the development of vaccines for hepatitis C, both hepatitis A and hepatitis B can be prevented by immunization. The purpose of this overview is to summarize and discuss the hepatitis vaccination in this population.

AB - Hepatitis virus infections are traditionally a major health problem among drug users (DUs). Several factors may favor the rapid spread of hepatitis infection in this category of patients. HBV and HCV are easily transmitted through exposure to infected blood and body fluids. DUs often prepare and use drug solutions together. Many in the DU community are infected and this provides multiple opportunities for transmission to others. Many of these patients with chronic hepatitis virus infection are not aware of their infections and this facilitates the spread of the diseases. Viral hepatitis is not inevitable for DUs. Although multiple factors have prevented the development of vaccines for hepatitis C, both hepatitis A and hepatitis B can be prevented by immunization. The purpose of this overview is to summarize and discuss the hepatitis vaccination in this population.

KW - Drug users

KW - HAV

KW - HBV

KW - HCV

KW - Hepatitis vaccination

UR - http://www.scopus.com/inward/record.url?scp=33644907164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644907164&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2005.12.045

DO - 10.1016/j.vaccine.2005.12.045

M3 - Review article

C2 - 16436307

AN - SCOPUS:33644907164

VL - 24

SP - 2702

EP - 2709

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 15

ER -